Meribank Biotech Co., Ltd (TPEX:4724)
Taiwan · Delayed Price · Currency is TWD 9.49
+0.10 (1.06%)
Jun 18, 2026, 2:56 PM CST
Meribank Biotech Market Cap
Meribank Biotech has a market cap or net worth of 910.81 million as of June 18, 2026. Its market cap has decreased by -31.21% in one year.
Market Cap
910.81M
Enterprise Value
1.82B
Revenue
471.76M
Ranking
n/a
PE Ratio
n/a
Stock Price
9.49
Market Cap Chart
Since June 16, 2023, Meribank Biotech's market cap has decreased from 1.95B to 910.81M, a decrease of -53.20%. That is a compound annual growth rate of -22.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 910.81M | -36.68% |
| Dec 31, 2025 | 1.44B | -41.61% |
| Dec 31, 2024 | 2.46B | 2.99% |
| Dec 29, 2023 | 2.39B | 22.90% |
| Jun 16, 2023 | 1.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Holy Stone Healthcare | 1.06B |
| Level Biotechnology | 1.01B |
| GeneReach Biotechnology | 991.34M |
| Lukas Biomedical | 986.14M |
| TCI GENE | 978.96M |
| U-Neuron Biomedical | 955.94M |
| Taiwan Advance Bio-Pharmaceutical | 913.50M |
| NatureWise Biotech & Medicals | 869.55M |